NCT03171545Completed
Enhancing the Cardiovascular Safety of Hemodialysis Care (Dialysafe)
Enhancing the Cardiovascular Safety of Hemodialysis Care: A Cluster-Randomized, Comparative Effectiveness Trial of Multimodal Provider Education and Patient Activation Interventions (Dialysafe)
Source: ClinicalTrials.gov · Last updated 14 Jan 2026
Brief summary (registry, in English)
The purpose of this study is reduce episodes of intradialytic hypotension, low blood pressure during a hemodialysis session, in patients with End Stage Renal Disease (ESRD). Recruitment will take place on the clinic level rather than the patient level.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 1431 (actual)
- First submitted
- 25 May 2017
- Start date
- 11 Jan 2023
- Primary completion date
- 17 Nov 2024
- Lead sponsor
- University of Michigan
- Diseases
- Chronic kidney disease
- NCT number
- NCT03171545
What you commit to
- Study type: Interventional
- Participants enrolled: 1431
- From 11 Jan 2023 to the primary completion date, 17 Nov 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Selection is at both the clinic level and individual patient level.
- Clinic Inclusion Criteria:
- outpatient hemodialysis facilities
- at least 70 adult (\>21 years old) patients to guarantee sample size
- Clinic Exclusion Criteria:
- facilities involved in another study
- facilities in immediate jeopardy
- facilities with 1-star quality ratings
- facilities designated as COVID-19 isolation facilities
- Individual Patient Exclusion Criteria:
- individual patients who are currently incarcerated
- individual patients who have poor cognition or cognitive impairment
- individual patients unable to comprehend the patient information sheet due to lack of facility in English or Spanish
- individual patients who have opted out of data collection
Age in the registry: 21 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fresenius Kidney Care University Of Michigan - Ann Arbor Coordinator of this site? Confirm its status | Ann Arbor | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.